Finland· FI-REL-REL21481
GALLIMUNE 302 ND+IB+EDS
A newcastlen virus/paramyksovirus- + lintujen tarttuva keuhkoputkentulehdusvirus-+ lintujen adenovirus product containing inactivated newcastle disease virus + inactivated infectious bronchitis virus + inactivated egg drop syndrome (eds) virus, registered in Finland by Boehringer Ingelheim Animal Health Nordics A/S. The same ATC class is registered in 2 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Inactivated newcastle disease virus + inactivated infectious bronchitis virus + inactivated egg drop syndrome (eds) virus is registered in 2 of 19 countries.
Countries holding a registration under ATC QI01AA13 (newcastlen virus/paramyksovirus- + lintujen tarttuva keuhkoputkentulehdusvirus-+ lintujen adenovirus), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 1 of them publish a price we can compare per daily dose
Inactivated newcastle disease virus + inactivated infectious bronchitis virus + inactivated egg drop syndrome (eds) virus · ATC QI01AA13
2 / 19 countries
- Denmark
- Finlandprice
The record
At a glance
Fimea (Finland)- Active substance
- Inactivated Newcastle Disease Virus + Inactivated Infectious Bronchitis virus + Inactivated Egg Drop Syndrome (EDS) virus
- Manufacturer
- Boehringer Ingelheim Animal Health Nordics A/S
- Country
- Finland (FI)
- ATC code
- QI01AA13
- ATC class
- Newcastlen virus/paramyksovirus- + lintujen tarttuva keuhkoputkentulehdusvirus-+ lintujen adenovirus
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under QI01AA13
Newcastlen virus/paramyksovirus- + lintujen tarttuva keuhkoputkentulehdusvirus-+ lintujen adenovirus, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/7e0b6eea-f485-487f-aca1-d05b782b7785 GET /v1/drugs/7e0b6eea-f485-487f-aca1-d05b782b7785?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "injektioneste, emulsio",
"route": "Lihakseen",
"ddd_unit": null,
"strength": null,
"atc_label": "Newcastlen virus/paramyksovirus- + lintujen tarttuva keuhkoputkentulehdusvirus-+ lintujen adenovirus",
"ma_number": "19475",
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": null,
"fimea_rel_id": "REL21481",
"authorised_at": "2014-12-08"
}See everything about inactivated newcastle disease virus + inactivated infectious bronchitis virus + inactivated egg drop syndrome (eds) virus.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.